KRAS and familial pancreatic carcinoma: In this report, in order to detect KRAS point mutations in pancreatic cancer cells we developed a novel, non-PCR molecular method, PNA-LNA mediated LAMP, which takes advantage of both LAMP technology and high sequence specific artificial nucleic acids.